CD38 and myeloproliferative disorder: In our study, no differences were seen when comparing pSTAT5 expression levels in CD34+/CD38− MPN-SC among the three groups of MPN patients, and in each case, pSTAT5 was homogenously expressed in all MPN-SC in all patients.